A Study of Capecitabine Plus Oxaliplatin in Combination With Pre-operative Pelvic Radiotherapy in Rectal Cancer

NCT02694718 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Rectal Cancer

Interventions

DRUG: Capecitabine
DRUG: Oxaliplatin

Sponsor

Hoffmann-La Roche

Collaborators

[object Object]